Latest News

Market for New Technology Continues to be Strong in face of Credit Crisis and Capital Gap

Contact:
Scott Milligan
312-622-3301
smilligan@accelitech.biz

Accelitech LLC, a leading developer of stereotactic radiosurgery and cancer treatment programs, spoke to industry peers in a two-day conference on October 20 and 21 aimed at addressing legal and business issues in the field of cancer care delivery.

Scott D. Milligan, Chief Development Officer of Accelitech, presented the following key points in his presentation titled New Technology: Economics and Joint Ventures in Radiosurgery:

  • Demand for SRS continues to be strong, driven by clinical outcomes, patient awareness and hospital business opportunity.
  • Technology options for SRS are increasing and creating market confusion and opportunity.
  • The hospital “capital gap” continues to widen with the credit crisis and market meltdown.
  • New Stark laws have made physician ventures more challenging (but possible), particularly when surgeons are involved.
  • The Accelitech Joint Venture Model may provide hospitals with attractive off balance sheet, per-use, no minimum lease arrangements.
  • All indications are that the Stereotactic Radiosurgery market will continue to be attractive for hospitals, patients, physicians and the developers who support them.

About 2008 Cancer Center Business Summit

The 2008 Cancer Center Business Summit, “Community Oncology at the Crossroads” was sponsored in part by Foley & Lardner LLP. The purpose of the event is to confront issues affecting community-based oncology providers as these entities experience declining reimbursements for chemotherapy and imaging services and increasing technology costs and competition in radiation therapy. The event was widely attended, attracting providers, payers, attorneys and developers alike.

About Accelitech LLC

Accelitech LLC is a leading developer of stereotactic radiosurgery programs. Headquartered in Chicago, Accelitech offers broad experience and resources in healthcare law, finance, development, and clinical operations. Accelitech provides the funds, expertise and legal models to allow physicians and hospitals to bring new technology to market for the benefit of the patients they serve. Accelitech currently has six sites in addition to several other projects under development throughout the United States.